RELATED CONTENT
Post-treatment surveillance with molecular imaging could mean the early start of a new, life-saving treatment for non-Hodgkin lymphoma (NHL), said researchers at the 2015 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI).
June 12, 2015 
A simple noninvasive blood test matched with state-of-the-art molecular imaging of individual cells could help oncologists understand their patients’ chances of survival, said researchers at the 2014 annual meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI).
June 20, 2014 
Patients with advanced breast cancer that may have spread to their lymph nodes could benefit from a more robust dose of a molecular imaging agent called Tc-99m filtered sulfur colloid when undergoing lymphoscintigraphy, a functional imaging technique that scouts new cancer as it begins to metastasize. Best results also indicate that imaging could be improved by injecting the agent the day prior to surgical resection, according to research unveiled at the 2014 annual meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI).
June 20, 2014 A simple noninvasive blood test matched with state-of-the-art molecular imaging of individual cells could help oncologists understand their patients’ chances of survival, said researchers at the Society of Nuclear Medicine and Molecular Imaging’s 2014 Annual Meeting (SNMMI).
June 18, 2014 June 18, 2014 — A new molecular imaging agent has been developed to help clinicians find as much cancer as possible, whether it is responding favorably or not, in an effort to improve clinical decision making for prostate cancer patients, said researchers at the 2014 annual meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI).
June 18, 2014 aycan is now listed as a manufacturer on NASA’s Solutions for Enterprise-Wide Procurement (SEWP) list through business partner and contract holder Alvarez & Associates.
June 13, 2014 For years researchers have been developing molecular imaging techniques that visualize hormonally active breast cancer cells — specifically those testing positive for human epidermal growth factor receptor 2 (HER2). A recent innovation in breast cancer biomarkers seeks the HER3 receptor instead, which could mean more comprehensive breast cancer imaging and potential treatments, say experts presenting data during the Society of Nuclear Medicine and Molecular Imaging’s 2014 Annual Meeting (SNMMI).
June 13, 2014 How many millions of people suffer from sleep disturbance? One sleep disorder in particular, called REM behavior disorder, could be a sign of impending neurodegenerative disease, including Parkinson’s and dementia, say scientists presenting their research at the Society of Nuclear Medicine and Molecular Imaging’s 2014 Annual Meeting.
June 12, 2014 Ischemic heart disease, a narrowing of the arteries supplying blood to the heart, is a leading cause of death throughout the world. A hybrid molecular imaging technique called positron emission tomography and magnetic resonance (PET/MR) imaging, which tells doctors vital information about cardiac and arterial function, has been found to be an effective molecular imaging tool for detecting coronary artery disease (CAD), say researchers at the Society of Nuclear Medicine and Molecular Imaging’s 2014 Annual Meeting (SNMMI).
June 12, 2014 
Many people develop depression in the latest stages of life, but until now doctors had no idea that it could point to a build up of a naturally occurring protein in the brain called beta-amyloid, a hallmark of Alzheimer’s disease. In fact, late-life depression could become a major risk factor for developing Alzheimer’s faster than others, according to research unveiled at the Society of Nuclear Medicine and Molecular Imaging’s 2014 Annual Meeting (SNMMI).
June 11, 2014